Koneksa

News

Regeneron joins Koneksa Parkinson's digital biomarker study

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patient

News

Koneksa aims to answer Parkinson's-tracking challenge with A...

Healthcare technology firm Koneksa will carry out a study to evaluate whether digital biomarkers can be used to track the progression of Parkinson's disease – thanks to a grant from the Mic

News

Bottles of prescription medicine in a pile. This collection of pill bottles is symbolic of the many medications senior adults and chronically ill people take.

Takeda looks to digitise drug trials with Koneksa

Takeda will integrate Koneksa's digital tools and analytics platform to improve their drug development pipeline.

Regeneron joins Koneksa Parkinson's digital biomarker study

Koneksa aims to answer Parkinson's-tracking challenge with A...

Takeda looks to digitise drug trials with Koneksa

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks